Premium
Management of advanced cutaneous T‐cell lymphoma: role of the dermatologist in the multidisciplinary team
Author(s) -
Poligone B.,
Querfeld C.
Publication year - 2015
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.13849
Subject(s) - medicine , multidisciplinary approach , dermatology , multidisciplinary team , lymphoma , pathology , nursing , social science , sociology
lymphoma: role of the dermatologist in the multidisciplinary team DOI: 10.1111/bjd.13849 DEAR EDITOR, Non-Hodgkin lymphoma is a heterogeneous group of lymphoproliferative disorders1 accounting for < 5% of cancers worldwide.2 Mycosis fungoides (MF) and the leu-kaemic variant Sezary syndrome are the most common sub-types of cutaneous T-cell lymphoma (CTCL).3 Early-stage MF is confined to the skin but may progress to cutaneous tumours/nodules and/or involve extracutaneous sites such as lymph nodes, blood or visceral organs.4 Advanced-stage dis-ease is associated with substantially reduced survival, with median overall survival of 47-14 years for patients with stage IIB–IVB disease.5 However, the clinical course is unpredictable and disease progression varies widely, with some patient